These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16918076)

  • 1. Homology modelling of the serotoninergic 5-HT2c receptor.
    Farce A; Dilly S; Yous S; Berthelot P; Chavatte P
    J Enzyme Inhib Med Chem; 2006 Jun; 21(3):285-92. PubMed ID: 16918076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convergence of melatonin and serotonin (5-HT) signaling at MT2/5-HT2C receptor heteromers.
    Kamal M; Gbahou F; Guillaume JL; Daulat AM; Benleulmi-Chaachoua A; Luka M; Chen P; Kalbasi Anaraki D; Baroncini M; Mannoury la Cour C; Millan MJ; Prevot V; Delagrange P; Jockers R
    J Biol Chem; 2015 May; 290(18):11537-46. PubMed ID: 25770211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and pharmacological evaluation of new series of naphthalenic analogues as melatoninergic (MT1/MT2) and serotoninergic 5-HT2C dual ligands (I).
    Ettaoussi M; Sabaouni A; Rami M; Boutin JA; Delagrange P; Renard P; Spedding M; Caignard DH; Berthelot P; Yous S
    Eur J Med Chem; 2012 Mar; 49():310-23. PubMed ID: 22301214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade.
    Millan MJ; Brocco M; Gobert A; Dekeyne A
    Psychopharmacology (Berl); 2005 Feb; 177(4):448-58. PubMed ID: 15289999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways.
    Millan MJ; Gobert A; Lejeune F; Dekeyne A; Newman-Tancredi A; Pasteau V; Rivet JM; Cussac D
    J Pharmacol Exp Ther; 2003 Sep; 306(3):954-64. PubMed ID: 12750432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacophore-directed homology modeling and molecular dynamics simulation of G protein-coupled receptor: study of possible binding modes of 5-HT2C receptor agonists.
    Zuo Z; Chen G; Luo X; Puah C; Zhu W; Chen K; Jiang H
    Acta Biochim Biophys Sin (Shanghai); 2007 Jun; 39(6):413-22. PubMed ID: 17558446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological evaluation of a series of the agomelatine analogues as melatonin MT1 /MT2 agonist and 5-HT2C antagonist.
    Ettaoussi M; Sabaouni A; Pérès B; Landagaray E; Nosjean O; Boutin JA; Caignard DH; Delagrange P; Berthelot P; Yous S
    ChemMedChem; 2013 Nov; 8(11):1830-45. PubMed ID: 24031039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of action of agomelatine: synergy between melatonergic and 5-HT2C receptors.
    Racagni G; Riva MA; Molteni R; Musazzi L; Calabrese F; Popoli M; Tardito D
    World J Biol Psychiatry; 2011 Dec; 12(8):574-87. PubMed ID: 21999473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The melatonergic agonist and clinically active antidepressant, agomelatine, is a neutral antagonist at 5-HT(2C) receptors.
    Millan MJ; Marin P; Kamal M; Jockers R; Chanrion B; Labasque M; Bockaert J; Mannoury la Cour C
    Int J Neuropsychopharmacol; 2011 Jul; 14(6):768-83. PubMed ID: 20946699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenesis analysis of the serotonin 5-HT2C receptor and a Caenorhabditis elegans 5-HT2 homologue: conserved residues of helix 4 and helix 7 contribute to agonist-dependent activation of 5-HT2 receptors.
    Xie J; Dernovici S; Ribeiro P
    J Neurochem; 2005 Jan; 92(2):375-87. PubMed ID: 15663485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological evidence for transactivation within melatonin MT
    Gerbier R; Ndiaye-Lobry D; Martinez de Morentin PB; Cecon E; Heisler LK; Delagrange P; Gbahou F; Jockers R
    FASEB J; 2021 Jan; 35(1):e21161. PubMed ID: 33156577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and pharmacological evaluation of dual ligands for melatonin (MT1/MT2) and serotonin 5-HT2C receptor subtypes (II).
    Ettaoussi M; Pérès B; Errazani A; Boutin JA; Caignard DH; Delagrange P; Melnyk P; Berthelot P; Yous S
    Eur J Med Chem; 2015 Jan; 90():822-33. PubMed ID: 25528336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational design of thermostabilizing point mutations for G protein-coupled receptors.
    Popov P; Peng Y; Shen L; Stevens RC; Cherezov V; Liu ZJ; Katritch V
    Elife; 2018 Jun; 7():. PubMed ID: 29927385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of new naphtho- and quinolinocyclopentane derivatives as potent melatoninergic (MT
    Duroux R; Rami M; Landagaray E; Ettaoussi M; Caignard DH; Delagrange P; Melnyk P; Yous S
    Eur J Med Chem; 2017 Dec; 141():552-566. PubMed ID: 29102176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of structural determinants of ligand selectivity in 5-HT₂ receptor subtypes on the basis of protein-ligand interactions.
    Jang JW; Kim MS; Cho YS; Cho AE; Pae AN
    J Mol Graph Model; 2012 Sep; 38():342-53. PubMed ID: 23085173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into binding modes of 5-HT2c receptor antagonists with ligand-based and receptor-based methods.
    Lu C; Jin F; Li C; Li W; Liu G; Tang Y
    J Mol Model; 2011 Oct; 17(10):2513-23. PubMed ID: 21203788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenesis Analysis Reveals Distinct Amino Acids of the Human Serotonin 5-HT
    Liu Y; Canal CE; Cordova-Sintjago TC; Zhu W; Booth RG
    ACS Chem Neurosci; 2017 Jan; 8(1):28-39. PubMed ID: 27580242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agomelatine affects rat suprachiasmatic nucleus neurons via melatonin and serotonin receptors.
    Yang J; Jin HJ; Mocaër E; Seguin L; Zhao H; Rusak B
    Life Sci; 2016 Jun; 155():147-54. PubMed ID: 27269050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the influence of 5-HT2c aminoacidic variants with the inhibitory action of serotonin inverse agonists and antagonists.
    Galeazzi R; Massaccesi L; Piva F; Principato G; Laudadio E
    J Mol Model; 2014 Mar; 20(3):2120. PubMed ID: 24562856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of a new antidepressant : agomelatine].
    Mocaër E; Delalleau B; Boyer PA; de Bodinat C
    Med Sci (Paris); 2005 Oct; 21(10):888-93. PubMed ID: 16197911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.